Saiseikai Yokohama-shi Tobu Hospital in cooperation with community medical facilities created a regional cooperative critical pathway for cases of gastric and colon cancer based on the methods of administering anticancer drugs. The hospital mainly serves the Kanagawa ward and Tsurumi ward of Yokohama City. Every month regular study sessions on digestive diseases are held for these two wards with the respective medical associations. During these sessions, after exchanging opinions with both associations and acquiring sufficient consent, the regional cooperative paths were created.
Considering practicality, three types of paths, based on the methods of administering anticancer drugs rather than on the stages, were created. Type A is a path with no administration of any anticancer drug. Type B is a path of the administration of UFT alone and Type C is a path with the administration of either TS-1 or UFT/UZEL, which both require a blood test before administration.
Subsequently, a questionnaire was distributed to the medical associations of each ward in order to verify their willingness to participate in these paths. The questionnaires were distributed to 189 institutions and answers were obtained from 104 institutions. Of these 104 institutions, 90 institutions expressed a desire to participate in the paths, of which 60 institutions agreed to the administration of anticancer drugs.
Registration began in January 2008 and 86 cases have been registered so far. 41 institutions are participating. In detail: 38 cases from 26 institutions with Stomach A, 1 case from 1 institution with Stomach B, 5 cases from 5 institutions with Stomach C, 31 cases from 17 institutions with Colon A, 11 cases from 8 institutions with Colon B and 0 case with Colon C. After approximately 6 months into the initiation of these paths no cases regarding problems of cooperation have emerged so far and that 86 cases have been registered from only 41 institutions shows the practicality of the initiative.
View full abstract